A detailed history of David Katz (Matrix Asset Advisors Inc) transactions in Pfizer Inc stock. As of the latest transaction made, Matrix Asset Advisors Inc holds 291,405 shares of PFE stock, worth $8 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
291,405
Previous 297,256 1.97%
Holding current value
$8 Million
Previous $8.32 Million 1.39%
% of portfolio
0.96%
Previous 0.99%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$27.7 - $31.39 $162,072 - $183,662
-5,851 Reduced 1.97%
291,405 $8.43 Million
Q2 2024

Jul 15, 2024

BUY
$25.26 - $29.6 $489,463 - $573,559
19,377 Added 6.97%
297,256 $8.32 Million
Q1 2024

Apr 15, 2024

BUY
$25.89 - $29.73 $1.8 Million - $2.06 Million
69,339 Added 33.25%
277,879 $7.71 Million
Q4 2023

Jan 24, 2024

BUY
$26.13 - $33.94 $373,789 - $485,511
14,305 Added 7.36%
208,540 $6 Million
Q3 2023

Oct 12, 2023

BUY
$32.09 - $37.51 $2.59 Million - $3.03 Million
80,761 Added 71.17%
194,235 $6.44 Million
Q2 2023

Jul 18, 2023

BUY
$36.12 - $41.79 $4.1 Million - $4.74 Million
113,474 New
113,474 $4.16 Million
Q4 2019

Feb 11, 2020

SELL
$32.92 - $37.36 $185,866 - $210,934
-5,646 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $6.56 Million - $8.51 Million
-201,950 Reduced 97.28%
5,646 $203,000
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $19,488 - $21,881
527 Added 0.25%
207,596 $8.99 Million
Q1 2019

May 10, 2019

SELL
$37.5 - $41.2 $60,112 - $66,043
-1,603 Reduced 0.77%
207,069 $8.79 Million
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $970,444 - $1.11 Million
-25,226 Reduced 10.79%
208,672 $9.11 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $509,845 - $618,411
-14,791 Reduced 5.95%
233,898 $10.3 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $60,155 - $64,131
-1,824 Reduced 0.73%
248,689 $9.02 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $135,968 - $157,742
4,261 Added 1.73%
250,513 $8.89 Million
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $199,460 - $211,634
5,997 Added 2.5%
246,252 $8.92 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $140,864 - $155,177
4,544 Added 1.93%
240,255 $8.58 Million
Q2 2017

Aug 09, 2017

BUY
N/A
10,138 Added 4.49%
235,711 $7.92 Million
Q1 2017

May 10, 2017

BUY
N/A
19,831 Added 9.64%
225,573 $7.72 Million
Q4 2016

Feb 08, 2017

BUY
N/A
20,084 Added 10.82%
205,742 $6.68 Million
Q3 2016

Nov 07, 2016

BUY
N/A
27,548 Added 17.42%
185,658 $6.29 Million
Q2 2016

Aug 03, 2016

BUY
N/A
1,726 Added 1.1%
158,110 $5.57 Million
Q1 2016

May 05, 2016

BUY
N/A
16,458 Added 11.76%
156,384 $4.64 Million
Q4 2015

Feb 08, 2016

BUY
N/A
3,803 Added 2.79%
139,926 $4.52 Million
Q3 2015

Nov 10, 2015

BUY
N/A
3,172 Added 2.39%
136,123 $4.28 Million
Q2 2015

Aug 07, 2015

BUY
N/A
11,312 Added 9.3%
132,951 $4.46 Million
Q1 2015

May 08, 2015

BUY
N/A
1,035 Added 0.86%
121,639 $4.23 Million
Q4 2014

Feb 10, 2015

BUY
N/A
11,823 Added 10.87%
120,604 $3.76 Million
Q3 2014

Nov 06, 2014

BUY
N/A
4,387 Added 4.2%
108,781 $3.22 Million
Q2 2014

Aug 11, 2014

BUY
N/A
14,784 Added 16.5%
104,394 $3.1 Million
Q1 2014

May 08, 2014

BUY
N/A
1,329 Added 1.51%
89,610 $2.88 Million
Q4 2013

Feb 07, 2014

BUY
N/A
16,425 Added 22.86%
88,281 $2.7 Million
Q3 2013

Nov 08, 2013

BUY
N/A
2,832 Added 4.1%
71,856 $2.06 Million
Q2 2013

Aug 13, 2013

BUY
N/A
69,024
69,024 $1.93 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track David Katz's Portfolio

Track David Katz Portfolio

Follow David Katz (Matrix Asset Advisors Inc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Matrix Asset Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Matrix Asset Advisors Inc and David Katz with notifications on news.